Portal de Periódicos da CAPES

Naltrexone implant and blood naltrexone levels over pregnancy

2003; Wiley; Volume: 43; Issue: 5 Linguagem: Inglês

10.1046/j.0004-8666.2003.00121.x

1479-828X

Gary Kenneth Hulse, Diane Arnold‐Reed, George O’Neil, Robert Hansson,

Maternal Mental Health During Pregnancy and Postpartum

Australian and New Zealand Journal of Obstetrics and GynaecologyVolume 43, Issue 5 p. 386-388 Naltrexone implant and blood naltrexone levels over pregnancy Gary K. Hulse, Corresponding Author Gary K. Hulse Unit for Research and Education in Drugs and Alcohol, School of Psychiatry and Clinical Neurosciences, University of Western Australia,Associate Professor GK Hulse, School of Psychiatry and Clinical Neurosciences, University of Western Australia, 35 Stirling Highway, Crawley, Western Australia 6009, Australia. Email: [email protected]Search for more papers by this authorDiane E. Arnold-Reed, Diane E. Arnold-Reed Unit for Research and Education in Drugs and Alcohol, School of Psychiatry and Clinical Neurosciences, University of Western Australia,Search for more papers by this authorGeorge O'Neil, George O'Neil Unit for Research and Education in Drugs and Alcohol, School of Psychiatry and Clinical Neurosciences, University of Western Australia, Australian Medical Procedures Research Foundation andSearch for more papers by this authorRobert C. Hansson, Robert C. Hansson Forensic Science Laboratory, Chemistry Centre (WA), Perth, AustraliaSearch for more papers by this author Gary K. Hulse, Corresponding Author Gary K. Hulse Unit for Research and Education in Drugs and Alcohol, School of Psychiatry and Clinical Neurosciences, University of Western Australia,Associate Professor GK Hulse, School of Psychiatry and Clinical Neurosciences, University of Western Australia, 35 Stirling Highway, Crawley, Western Australia 6009, Australia. Email: [email protected]Search for more papers by this authorDiane E. Arnold-Reed, Diane E. Arnold-Reed Unit for Research and Education in Drugs and Alcohol, School of Psychiatry and Clinical Neurosciences, University of Western Australia,Search for more papers by this authorGeorge O'Neil, George O'Neil Unit for Research and Education in Drugs and Alcohol, School of Psychiatry and Clinical Neurosciences, University of Western Australia, Australian Medical Procedures Research Foundation andSearch for more papers by this authorRobert C. Hansson, Robert C. Hansson Forensic Science Laboratory, Chemistry Centre (WA), Perth, AustraliaSearch for more papers by this author First published: 07 October 2003 https://doi.org/10.1046/j.0004-8666.2003.00121.xCitations: 18Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Rementeria JL, Lotongkhum L. The fetus of the drug addicted woman: conception, fetal wastage and complications. In: JL Rementeria (ed). Drug Abuse in Pregnancy and Neonatal Effects. St Louis: CV Mosby, 1977; 3– 18. 2 Hulse GK, Milne E, English DR, Holman CDJ. Assessing the relationship between maternal opiate use and antepartum haemorrhage. Addiction. 1998; 93: 1553– 1558. 3 Hulse GK, Milne E, English DR, Holman CD. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction. 1997; 92: 1571– 1579. 4 Hulse GK, Milne E, English DR, Holman CDJ. Assessing the relationship between maternal opiate use and neonatal mortality. Addiction. 1998; 93: 1033– 1042. 5 Ellwood DA, Sutherland P, Kent C, O'Connor M. Maternal narcotic addiction: pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic. Aust NZ J Obstet Gynecol. 1987; 27: 92– 98. 6 Lam S, To W, Duthie S, Ma H. Narcotic addiction in pregnancy with adverse maternal and perinatal outcome. Aust NZ J Obstet Gynecol. 1992; 32: 216– 221. 7 Julius D. NIDA's Naltrexone Research Program. In: D Julius, P Renault (eds). Narcotic Antagonists: Naltrexone (NIDA Research Monograph No: 9). Rockville, MD: National Institute of Drug Abuse, 1976; 5– 11. 8 Tennant FS, Rawson RA, Cohen AJ, Mann A. Clinical experience with naltrexone in suburban opioid addicts. J Clin Psych. 1984; 45: 42– 45. 9 Hulse G, O'Neill G. Using naltrexone implant in the management of the pregnant heroin user. Aust NZ J Obstet Gynecol. 2002; 42: 569– 573. 10 Bugge CJL, Grun I, Stanfor K, Tan MS, Garcia DB. Determination of naltrexone and 6-b-naltrexol in human plasma by LC-MS-MS. Texas: CEDRA Corporation, 1996. Available from: http://www.cedracorp.com/naltrex.htm 11 Hulse GK, Arnold-Reed DE, Hansson R, O'Neil G, Chan C. Blood naltrexone and 6-naltrexol levels following double or single naltrexone implant. In: RM Eisenberg (ed). Sixty-fifth Annual Scientific Meeting of the College on Problems of Drug Dependence. Bal Harbour, FL: College on Problems of Drug Dependence, 2003: 72. Citing Literature Volume43, Issue5October 2003Pages 386-388 ReferencesRelatedInformation